Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Anabolic-androgenic steroids can cause skin issues like acne and oily skin by enlarging oil glands and changing skin oils.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Finasteride side effects in young men may be linked to specific gene variations.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

A small percentage of minoxidil users may develop an allergic skin reaction.

5α-reductases increase epitestosterone's effect on androgen receptors.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.